The customer stated that a physician is questioning falsely depressed alinity i vitamin d results for a male patient who had been prescribed vitamin d supplements.The patient had multiple unnecessary lab tests and subsequent visits to sub-specialists due to "low vitamin d" in the setting of high dose vitamin d replacement.The patient also had additional visits to endocrinology and gi specialists, as well as a visit to the hospital.He also had an unnecessary endoscopy procedure to rule out mal-absorptive disorders causing low vitamin d despite therapy.The following data was provided (reference range for vitamin d 30 to 80 ng/ml): sid not provided result from (b)(6) 2021 ((b)(4)) 21 ng/ml; sid (b)(6) results from (b)(6) 2021 ((b)(4)) 13 ng/ml; sid (b)(6) result from (b)(6) 2021 ((b)(4)) 29 ng/ml; the medical provider sent a duplicate sample to (b)(6) on (b)(6) 2021 and the following data was provided: (b)(6) results d2: 27 ng/ml, d3: 61 ng/ml, total: 88 ng/ml.The patient had an unnecessary endoscopy procedure to rule out malabsorptive disorders causing low vitamin d despite therapy.
|
Additional information was received from the customer indicating that the patient is 69 years old with a history of cardiomyopathy status post pacemaker placement, cerebrovascular incident, warfarin therapy, osteoporosis, and vitamin d deficiency.The outcome of the endoscopy was that the patient had a very benign upper endoscopy.No cause for his vitamin d deficiency or gi symptoms was observed.
|
The complaint investigation included a search for similar complaints, and the review of complaint text, attached data, trending data, labelling, and device history records.Return testing was not completed as returns were not available.In-house testing was completed.The ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review determined no related trend for the issue for the product.Device history record review did not identify any issues associated with lot 19441ui00.Labelling was reviewed and found to adequately address the issue under review.A test protocol was completed using retained quality file samples and all acceptance criteria was met.As per product labelling, results should be used in conjunction with other data; e.G., symptoms, results of other tests, and clinical impressions.If the 25-oh vitamin d results are inconsistent with clinical evidence, additional testing is recommended.When testing samples from patients whose predominant form of vitamin d is vitamin d2, such as patients receiving vitamin d2 supplementation, results that are subtherapeutic should be confirmed with another method, such as lc-ms/ms, before being used for patient management.Product labelling provides information on possible reasons for false depressed results and potentially interfering substances.Based on the investigation, no systemic issue or deficiency of the alinity i 25-oh vitamin d reagent lot 19441ui00 was identified.
|